ARYN Aryzta AG

Aryzta AG: Regulatory Release to Irish Stock Exchange - Total Voting Rights and Share Capital

Aryzta AG: Regulatory Release to Irish Stock Exchange - Total Voting Rights and Share Capital

Schlieren/Switzerland, 5 February 2020

 In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, ARYZTA AG advises that:

The total number of registered shares of nominal value CHF0.02 each in issue as of the date of this notice is 993,105,727

The Company holds 1,981,904 registered shares in treasury. Therefore, the total number of voting rights is 991,123,823

The above figure of 991,123,823 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the (Irish) Transparency (Directive 2004/109/EC) Regulations 2007 and the Transparency Rules.

This announcement is made by ARYZTA arising from the requirements of its secondary listing on the Euronext Dublin (ISE).

ARYZTA AG (‘ARYZTA’) is a global food business with a leadership position in speciality bakery. ARYZTA is based in Schlieren, Switzerland, with operations in North America, South America, Europe, Asia, Australia and New Zealand. ARYZTA has a primary listing on the SIX Swiss Exchange and a secondary listing on the Euronext Dublin (ISE) (SIX: ARYN, ISE: YZA).

Enquiries:

Gerard Wichers

 

 



 

EN
05/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aryzta AG

Christian Arnold ... (+2)
  • Christian Arnold
  • Tobias Fahrenholz

ODDO : Swiss Equities Conference Feedback – Difficult Q2 but some H2 2...

ODDO BHF and Commerzbank jointly hosted the Swiss Equities Conference in Interlaken, Switzerland, from 10 to 12 June 2025. The event was attended by 64 companies (out of which 59 are listed, and with BASF one non-Swiss company). Some 125 investors met mostly (85%) C-level management in 440 meetings (one-on-one, one-to-few) and plenary sessions, resulting in some 1,100 interactions. Based on our positive assessments for Q2 & H2 2025 as well as beyond, we would like to highlight Accelleron (poten...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch